. Dynamic light scattering of non-ionic compounds. Buffer and DMSO alone (a), compound 4 (b), and compound 6 (c) show no aggregation. Compound 7 (d) exhibits large ~ 100 nm radius aggregates. All compounds were at 1.56 µM concentration in 2% DMSO. 
In the absence of inhibitor equation 1 simplifies to equation 2 below.
The slope of each line is equal to
where K c = D•I/DI is the competitive inhibition equilibrium constant and K' c = DS•I/DSI is the noncompetitive equilibrium constant (D, I, DI, DS, and DSI are the molar cocentrations of dimer, inhibitior, dimer-inhibitor, dimer-substrate, and dimer-substrate-inhibitor, respectively). The noncompetitive rate constant, k' cat , is the rate of conversion of dimer-substrate-inhibitor complex to dimer-inhibitor plus product. Dissociative inhibition (dimer disruption) results in an increasing intercept with increasing inhibitor concentration. Purely disossciative inhibition results in a constant slope while mixed-type inhibition results in variable slope with varying inhibitor concentration.
Supplemental derivation 1:
In our Zhang-Poorman analysis with both DD2 and compound 2, increasing inhibitor concentration resulted in decreasing slope. This indicates that the derivative of the slope term with respect to inhibitor concentration (a) must be less than zero (b). To investigate whether this could inform mode of binding we solved this inequality.
Solving (b) while assuming all constants greater than 0, it follows that:
Since inhibition takes place we assume k' cat < k cat , therefore in combination with (c):
Since K' c is less than K c , apparent binding of inhibitor to the dimer-substrate-inhibitor complex is tighter than binding of inhibitor to the dimer alone. Without additional knowledge of k' cat , K c , or
is uninformative, though necessarily true for the above interpretation.
Supplemental Methods:
Site-Directed Mutagenesis
All DNA plasmids were produced by mutagenesis of the template sequences using a QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent). The resulting PCR-reaction mixtures were first transformed into XL-10 Gold Ultracompetent Cells (Agilent). Cultures containing the XL-10 transformed cells were grown overnight in Luria Broth containing carbenicillin (100 mg/mL) and miniprepped using Qiagen Miniprep Kits. DNA sequences of the mutated plasmids were verified via DNA sequencing prior to re-transformation into Rosetta2
(DE3) pLysS Competent Cells (Novagen/EMD Millipore). Primers (Integrated DNA Technologies, Inc.) encoding the isoleucine to valine mutations are listed in Table S1 , below. 
Crystallographic data processing
Diffraction images were processed using MOSFLM 2 and the CCP4 suite 3 (specifically SCALA/Truncate), operated through the Elves scripts. 4 The resulting structure was solved by molecular replacement with Phaser 5 using PDB 3NJQ as the template search model. The resulting structure model was a dimer in an asymmetric unit and was subjected to multiple rounds of restrained refinement and isotropic B-factor minimization with Phenix 6 and Coot.
7
"Riding" hydrogens were included during refinement.
Analog synthesis
1 H NMR spectra were recorded on a Varian INOVA-400 400 MHz spectrometer. Chemical shifts are reported in ! units (ppm) relative to TMS as an internal standard. Coupling constants (J) are reported in hertz (Hz). 13 C NMR spectra were recorded on a Bruker Avance 500 MHz spectrometer equipped with a QCI CyroProbe. All other reagents and solvents were purchased from Sigma-Aldrich and used as received. Air and/or moisture sensitive reactions were carried out under an argon atmosphere in oven-dried glassware using anhydrous solvents from commercial suppliers. Air and/or moisture sensitive reagents were transferred via syringe or cannula and were introduced into reaction vessels through rubber septa. Solvent removal was accomplished with a rotary evaporator at ca. 10-50 Torr. Column chromatography was carried out using a Biotage SP1 flash chromatography system and silica gel cartridges from Biotage.
Analytical TLC plates from EM Science (Silica Gel 60 F254) were employed for TLC analyses.
Hydrogenation reactions were carried out with a ThalesNano H-Cube hydrogenator.
All synthesized analogs were judged to be of 95% or higher purity based on analytical
LC/MS analysis. LC/MS analyses were performed on a Waters Micromass ZQ/Waters 2795
Separation Module/Waters 2996 Photodiode Array Detector system controlled by MassLynx 4.0 software. Separations were carried out on an XTerra® MS C 18 5µm 4.6x50mm column at ambient temperature using a mobile phase of water-acetonitrile containing 0.05% trifluoroacetic acid. Gradient elution was employed wherein the acetonitrile-water ratio was increased linearly from 5 to 95% acetonitrile over 2.5 minutes, then maintained at 95% acetonitrile for 1.5 min., and then decreased to 5% acetonitrile over 0.5 min, and maintained at 5% acetonitrile for 0.5 min. Compound purity was determined by integrating peak areas of the liquid chromatogram, monitored at 254 nm. Compound 2 was a cream-colored powder. Compounds 1 and 3-7 were white powders.
N-(2-Benzyl-4-carbamoyl-phenyl)-6-(cyclohexylmethyl)pyridine-2-carboxamide (4) 3-
Benzyl-4- [[6-(cyclohexylmethyl) 145.6, 136.1, 135.8, 135.5, 127.8, 127.7, 127.5, 125.9, 125.6, 124.5, 124.0, 123.8, 118.2, 116.9, 29.8, 23.3, 23 7, 160.6, 159.9, 151.9, 148.4, 144.5, 139.0, 138.4, 131.7, 131.4, 128.6, 128.3, 128.2, 127.7, 127.0, 126.6, 126.4, 125.1, 124.8, 123.5, 122.0, 119.4, 44.8, 37.8, 37.0, 32.5, 26.0, 25.6 " N-(2-Benzyl-4-cyanophenyl)-6-(cyclohexylmethyl)pyridine-2-carboxamide ( 9, 160.0, 147.8, 140.0, 138.5, 137.9, 134.6, 131.8, 131.7, 128.7, 128.2, 127.4, 126.7, 121.6, 119.7, 118.9, 106.4, 44.8, 37.8, 36.4, 32.5, 26.0, 25.6 N-[2-Benzyl-4-(1H-1,2,3,4-tetrazol-5-yl)phenyl]-6-(cyclohexylmethyl)pyridine-2-carboxamide (2) N-(2-Benzyl-4-cyanophenyl)-6-(cyclohexylmethyl)pyridine-2-carboxamide ( 7, 14 mg, 0.034 mmol), sodium azide (9 mg, 0.13 mmol), zinc bromide (8 mg, 0.034 mmol) in a 1:2 mixture of 2-propanol/water (0.9 mL) were heated to reflux for 60 h. 3, 160.3, 148.6, 139.0, 138.8, 132.2, 129.8, 129.1, 128.7, 127.6, 127.0, 126.4, 122.64, 119.9, 45.2, 38.2, 37.3, 32.9, 26.4, 26 .0. 4, 162.9, 162.5, 160.5, 148.3, 140.4, 138.9, 132.2, 131.4, 129.1, 128.6, 127.8, 127.1, 125.7, 121.5, 120.0, 52.6, 45.2, 38.3, 37.1, 32.9, 26.4, 26 .0.
Dynamic light scattering
Inhibitors were diluted from concentrated DMSO stocks to buffer with a final DMSO concentration of 2%. Measurements were made on a DynaPro MS/X equipped with a 55 mM laser at 826.6 nm. The integration time was 100 s (10x10 sec) and laser power was 100% unless reduction in laser power was necessary to avoid saturating the detector. The detector angle was
